Franklin Resources’s Stoke Therapeutics STOK Stock Holding History

Franklin Resources’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.65M	Buy	142,793 +10,571	+8%	+$347K	﹤0.01%	1551
2025 Q4	$4.2M	Buy	132,222 +16,389	+14%	+$493K	﹤0.01%	1480
2025 Q3	$2.72M	Buy	115,833 +34,438	+42%	+$590K	﹤0.01%	1668
2025 Q2	$924K	Buy	81,395 +59,081	+265%	+$561K	﹤0.01%	2030
2025 Q1	$148K	Hold	22,314	–	–	﹤0.01%	2759
2024 Q4	$246K	Hold	22,314	–	–	﹤0.01%	2584
2024 Q3	$285K	Sell	22,314 -1,193,886	-98%	-$16.9M	﹤0.01%	2510
2024 Q2	$16.4M	Buy	1,216,200 +157,900	+15%	+$2.13M	0.01%	923
2024 Q1	$14.3M	Buy	+1,058,300	New	+$6.41M	﹤0.01%	964
2023 Q3	–	Sell	-12,643	Closed	-$134K	–	2776
2023 Q2	$134K	Buy	+12,643	New	+$135K	﹤0.01%	2479

Other funds holding STOK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources's STOK Position: Q1 2026 in Review

Franklin Resources increased its Stoke Therapeutics (STOK) stake by 8% in Q1 2026, buying an estimated $347K and bringing the position to 142,793 shares worth $4.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Franklin Resources first reported a position in STOK in Q2 2023 and has held it in 10 quarters since. The position peaked at $16.4M in Q2 2024. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

Franklin Resources held 142,793 shares of Stoke Therapeutics worth $4.65M as of Q1 2026.
Franklin Resources bought 10,571 Stoke Therapeutics shares in Q1 2026, an estimated $347K.
Stoke Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1551 holding.
Franklin Resources first reported a position in Stoke Therapeutics in Q2 2023 and has held it in 10 quarters since.
Franklin Resources's Stoke Therapeutics position peaked at $16.4M in Q2 2024.
196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.